190 active not recruiting. 190 Phase 2, 28 Phase 1, 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 190 | Active not recruiting 190 |
| Phase 1 | 28 | Active not recruiting 28 |
| Phase 3 | 10 | Active not recruiting 10 |
Follow Biospecimen Collection: new trials by email Literature Review of Biospecimen Collection trials Research Report on Biospecimen Collection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Aplastic Anemia | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 1 | 2025-09-25 | 2026-05-22 |
| Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 20 | 2024-12-16 | 2026-09-09 |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer Biopsy, Biospecimen Collection, Computed Tomography - Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 2 | Active not recruiting | Mayo Clinic | 24 | 2024-12-06 | 2026-06-18 |
| Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer Biospecimen Collection, Computed Tomography, Immunotherapy - Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Active not recruiting | Mayo Clinic | 3 | 2024-11-14 | 2026-10-15 |
| Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma Biospecimen Collection, Computed Tomography, Echocardiography - B-Cell Non-Hodgkin Lymphoma | Phase 2 | Active not recruiting | Northwestern University | 11 | 2024-09-30 | 2026-09-14 |
| The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer Nab paclitaxel, Gemcitabine, Cisplatin - Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma | Phase 2 / Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 10 | 2024-08-13 | 2026-10-19 |
| Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial) Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 105 | 2024-08-01 | 2026-10-22 |
| Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 58 | 2024-07-23 | 2026-09-25 |
| Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial Avelumab, Biopsy Procedure, Biospecimen Collection - Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 50 | 2024-05-21 | 2026-07-31 |
| Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Computed Tomography - Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Active not recruiting | Mayo Clinic | 110 | 2024-04-22 | 2026-09-25 |
| Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) Binimetinib, Biopsy Procedure, Biospecimen Collection - Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 17 | 2024-02-09 | 2026-10-19 |
| Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors Biospecimen Collection, Chest Radiography, Computed Tomography - Adult Ovarian Granulosa Cell Tumor | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 17 | 2024-02-08 | 2026-07-28 |
| Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma Biopsy, Biospecimen Collection, Computed Tomography - Classic Hodgkin Lymphoma | Phase 2 | Active not recruiting | Northwestern University | 30 | 2024-02-06 | 2026-07-13 |
| Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma Biopsy, Biospecimen Collection, Computed Tomography - Locally Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma | Phase 2 | Active not recruiting | University of Kansas Medical Center | 15 | 2024-02-01 | 2026-02-24 |
| Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Follicular Lymphoma | Phase 2 | Active not recruiting | City of Hope Medical Center | 29 | 2024-01-24 | 2026-08-26 |
| A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | Children's Oncology Group | 78 | 2024-01-08 | 2026-08-25 |
| Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment Biospecimen Collection, Erdafitinib, Magnetic Resonance Imaging - Recurrent Glioma, Recurrent WHO Grade 2 Glioma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 30 | 2024-01-04 | 2026-10-15 |
| Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial Binimetinib, Biopsy Procedure, Biospecimen Collection - Exocrine Pancreas Carcinoma, Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 199 | 2023-12-13 | 2026-08-21 |
| Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer Atezolizumab, Biospecimen Collection, Capecitabine - Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 2 | 2023-12-06 | 2026-07-01 |
| Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters Acetaminophen, Biospecimen Collection, Broccoli Sprout/Broccoli Seed Extract Supplement - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 72 | 2023-12-04 | 2026-09-23 |
Showing 20 of 190. Sign in to see all of them.
Multiple Myeloma (17) · Lymphoma (15) · Lung Neoplasms (10) · Glioma (9) · Leukemia, Myeloid, Acute (9) · Neoplasm Metastasis (9) · Prostatic Neoplasms (9) · Ovarian Neoplasms (8) · Cholangiocarcinoma (7) · Colorectal Neoplasms (7) · Fallopian Tube Neoplasms (7) · Pancreatic Neoplasms (7) · Sarcoma (7) · Carcinoma, Non-Small-Cell Lung (6) · Lymphoma, Large B-Cell, Diffuse (6)
National Cancer Institute (NCI) (132) · Mayo Clinic (17) · Children's Oncology Group (6) · City of Hope Medical Center (6) · Northwestern University (5) · University of Washington (4) · Alliance for Clinical Trials in Oncology (3) · Fred Hutchinson Cancer Center (3) · ECOG-ACRIN Cancer Research Group (2) · NRG Oncology (2) · OHSU Knight Cancer Institute (2) · Academic and Community Cancer Research United (1) · Casey Cosgrove (1) · David Bond, MD (1) · M.D. Anderson Cancer Center (1)
United States (190) · Canada (27) · Puerto Rico (19) · Australia (6) · Guam (4) · New Zealand (2) · Israel (1) · Italy (1)
A P Chen (4) · David S Hong (3) · Patricia M LoRusso (3) · Alain C Mita (2) · Amer M Zeidan (2) · Anjali S Advani (2) · John L Hays (2) · Joyce F Liu (2) · Kristen R Spencer (2) · Marwan G Fakih (2) · Rana R McKay (2) · Rory M Shallis (2) · Timothy A Yap (2) · Aarti Bhatia (1) · Ahmad Tarhini (1)
PMID 23810467, PMID 25218906, PMID 26586415, PMID 28223062, PMID 29223478, PMID 31151904, PMID 31401903, PMID 31413177, PMID 31969335, PMID 32463741, PMID 32853585, PMID 33020646, PMID 33048619, PMID 33049057, PMID 33067126, PMID 33362722, PMID 33394722, PMID 33591402, PMID 33604999, PMID 33754642, PMID 33882143, PMID 34331515, PMID 34380663, PMID 34416167, PMID 34486544, PMID 34552007, PMID 34634256, PMID 34686472, PMID 34716198, PMID 35007127, PMID 35115306, PMID 35133871, PMID 35138919, PMID 35288469, PMID 35353553, PMID 35613998, PMID 35622074, PMID 36322825, PMID 36351402, PMID 36521030, PMID 36648215, PMID 36856617, PMID 37053535, PMID 37104746, PMID 37185961, PMID 37322121, PMID 37505794, PMID 37672694, PMID 37824137, PMID 37934000
U10CA180820 (31), UM1CA186689 (16), U10CA180888 (14), U10CA180821 (13), U10CA180886 (11), U10CA180868 (10), P30CA060553 (9), UM1CA186709 (9), UM1CA186712 (8), UM1CA186644 (7), P30CA033572 (6), UM1CA186691 (6), UM1CA186704 (6), UM1CA186716 (6), UM1CA186686 (5)